Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Latest Updates
Three Trends Guiding the Biopharmaceutical Industry in 2023
The biopharmaceutical industry faces a future shaped by uncertainty in the wake of the pandemic-influenced world, yet overall growth is expected to continue.
With rising incidences of cancer, it is estimated that HPAPI that cause biological response even at low doses will breach the $34bn mark in the next 3 years.
Three Novel Ways Tested By CMS To Lower The Cost of Drugs
Federal Health Agencies have selected three new models in line with the executive order by President Joe Biden to make sure that the drug costs are lowered.
Clinical Trials Diversity Continues To Be Area To Watch For
By giving the Diversity Action Plans to the FDA, pharma companies are looking to give sufficient significance to increasing the clinical trials universe size.
Gene Therapy Trials - A Word of Advice From FDA Officials
The gene therapy clinical trials are subject to the diseases that are being treated and that the those with a rapid onset may very well have shorter trials.
Long Term Survival In Lung Cancer Can Be A Possibility
A phase II historical analysis suggests that the intake of neoadjuvant nivolumab enhanced the five-year recurrence free lung cancer survival amongst patients.
